SCHOTT Takes adaptiQ System to Full-Scale Production

SCHOTT is advancing to full-scale production its new adaptiQ system for ready-to-use pharmaceutical vials at the company’s U.S. facility in Lebanon, PA, in preparation for commercial launch early in 2015. At the same time, the U.S. syringe production line will be transferred to SCHOTT’s Center of Excellence for Pharmaceutical Packaging Solutions in St. Gallen, Switzerland.

Designed in close collaboration with filling-line manufacturers, adaptiQ consists of a nest that securely holds as many as 100 clean and sterile vials in an industry-standard tub. Users can load these directly onto their filling lines without having to perform processing steps, such as washing, drying, and sterilizing, according to the company. The new nested packaging also helps protect the glass containers from scratches caused by vial-to-vial and vial-to-machine contact.

“Since introducing the adaptiQ concept at CPhI Worldwide 2014, we have received strong interest from our customers,” said Christopher Cassidy, vice president sales and marketing, North America for the Pharmaceutical Packaging Business Unit at SCHOTT. “Based on the positive feedback from the market, we now plan to allocate even more of our U.S. manufacturing resources to the production of adaptiQ vials.”
 
SCHOTT’s adaptiQ vials will be available for purchase early in 2015, initially in the ISO formats: 2R and 4R. SCHOTT will gradually introduce adaptiQ in all common ISO formats, from 2R to 30R. Samples are now available for evaluation.